Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.5283
-0.0084 (-1.57%)
At close: Feb 27, 2026, 4:00 PM EST
0.5400
+0.0117 (2.21%)
After-hours: Feb 27, 2026, 7:59 PM EST
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $38.81 million as of February 27, 2026. Its market cap has increased by 34.37% in one year.
Market Cap
38.81M
Enterprise Value
-57.69M
1-Year Change
34.37%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $38.81M, a decrease of -90.91%. That is a compound annual growth rate of -42.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 39.42M | 17.30% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rallybio | 39.81M |
| Klotho Neurosciences | 39.09M |
| Atara Biotherapeutics | 39.08M |
| Jasper Therapeutics | 38.62M |
| Sensei Biotherapeutics | 38.60M |
| Atossa Therapeutics | 38.15M |
| NovaBay Pharmaceuticals | 37.62M |
| Tvardi Therapeutics | 37.43M |